Company Positioned to Support Public Health through Vaccine Efficacy Testing and Data-Driven Insights into Patients' Immune Profiles to Empower Informed Decisions on Vaccination LONDON, Feb. 25 ...

USA, subsidiary offices in 10 countries, and over 60 distribution partners around the world. For more information about New England Biolabs, visit www.neb.com. Investors are grappling with a slew ...

TASS/. The US scientist who led the medical journal Lancet’s investigation of the origin of COVID-19, Jeffrey Sachs, has agreed to interact with the Russian parliamentary commission probing into ...

American journalist Tucker Carlson called on the world to investigate the crimes of Vladimir Zelensky, whom he considers ...

Virax Biolabs has entered into a definitive agreement for the issuance and sale of an aggregate of 1,108,892 of its ordinary ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced ...

TASS/. Russia’s parliamentary commission on investigating the activities of US biolabs in Ukraine will organize a videoconference with lawmakers in other countries to discuss the probe’s ...

Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research.

Virax Biolabs is positioned to advance vaccine transparency in collaboration with companies developing vaccines. Our cutting-edge technology enables us to provide research-based tools to measure ...

Virax Biolabs is positioned to advance vaccine transparency in collaboration with companies developing vaccines. Our cutting-edge technology enables us to provide research-based tools to measure ...